|Prof. Irene Oi-Lin Ng||The University of Hong Kong|
|Dr. Anna Brooks||University of Auckland, New Zealand|
|Dr. Anis Larbi||Singapore Immunology Network, A*STAR|
|Dr. Attila Tarnok||University of Leipzig, Germany|
|Dr. Bill Telford||NCI Experimental Transplantation and Immunology Branch|
|Dr. David Hedley||Princess Margaret Hospital|
|Dr. Elizabeth Forbes-Blom||Malaghan Institute of Medical Research, Wellington, New Zealand|
|Dr. Evan Newell||Singapore Immunology Network, A*STAR|
|Dr. Jinmiao Chen||Singapore Immunology Network, A*STAR|
|Dr. Jordi Petriz||José Carreras Leukaemia Foundation|
|Prof. Keisuke Goda||University of Tokyo|
|Dr. Matthew Linden||University of Western Australia|
|Dr. Narinder Mehra||All India Institute of Medical Sciences, New Delhi|
|Prof. Paul Wallace||International Society for the Advancement of Cytometry (ISAC)|
|Mr. Simon Monard||The Walter Eliza Hall Institute|
|Dr. Susanna Mandruzzato||University of Padova, Italy|
|Dr. Thomas Ashhurst||University of Sydney|
|Dr. Xunbin Wei||Shanghai Jiao Tong University|
|Prof. Alberto Orfao||University of Salamanca|
|Dr. Andrea Cossarizza||University of Modena and Reggio Emilia School of Medicine|
|Dr. Brent Wood||University of Washington|
|Prof. Elaine Coustan-Smith||National University of Singapore|
|Prof. Salvatore Albani||SingHealth Translational Immunology and Inflammation Centre|
|Dr. Sindhu Cherian||University of Washington, Seattle|
|Ms. Teri Oldaker||Genoptix Medical Laboratory, California|
Prof. Irene Oi-Lin Ng
Chair Professor, Head of Department of Pathology and Loke Yew Professor in Pathology
The University of Hong Kong
Professor Irene Oi-Lin Ng is Chair Professor and Head of Department of Pathology and Loke Yew Professor in Pathology at The University of Hong Kong; she is also the Director of the State Key Laboratory for Liver Research. She is the Chief of Service of Department of Pathology at Queen Mary Hospital.
Prof. Ng’s research work focuses on the molecular pathogenesis of liver cancer, including liver cancer stem cells and identification and characterization of important genes and signaling pathways. Her research studies have provided insight in the understanding of liver cancer development and may help identify potential targets in novel cancer therapy.
She has published more than 300 peer-reviewed journal articles. She is among the top 1% of most cited scientists in ‘Clinical Medicine’ and ‘All Fields’ of ISI Essential Science Indicators. She has received a number of awards including The World Academy of Science (Medical Science) 2014, Croucher Senior Medical Fellowship (2013 and 2005), and University of Hong Kong Outstanding Researcher Award. Prof. Ng is the pathologist responsible for liver transplantation pathology service at Queen Mary Hospital.
Prof. Alberto Orfao
Full Professor, Department of Medicine
University of Salamanca
Alberto Orfao is currently Full Professor of the Department of Medicine and Scientific Director of both the General Cytometry Service and the Cell sorting Service at the University of Salamanca, the Spanish National DNA Bank (Ministry of Economy and Competitivity) and the Network of Tumor Biobanks of Castilla y Leon (Spain).
His research activities are based on his position as one of the Principal Investigators at the Cancer Research Center of Salamanca and they are mainly focused on the field of hematological malignancies and the relationship between the immune system and cancer. He has contributed to over 650 publications and book chapters, being co-author of over 550 scientific papers in international journals, with an overall h-index of 62 and more than 16,000 accumulated citations; in addition, he is the inventor of 37 (granted/pending) patents. He has received over 40 awards and recognitions including the Berend Howen and the Wallace Coulter awards of the International Society for Laboratory Hematology and the International Society for Clinical Cytometry, respectively, and the 2012 Castilla and Leon Prize for Scientific and Technical Research and the Valdes-Salas Prize of the University of Oviedo (Spain).
He is currently member of the external scientific committees of several research institutions in Brasil, Spain and other European countries, and he is member of multiple national and international scientific evaluation panels and groups, including the EuroFlow Consortium (co-chair), European Scientific Foundation for Laboratory Hemato-Oncology (ESLHO) and the European Leukemia Net (ELN). He is/has been also member of the editorial board of several scientific journals, such as Leukemia, Haematologica, Human Genetics and Cytometry B.
Dr. Andrea Cossarizza
Director of the School of Specialization in Clinical Pathology
University of Modena and Reggio Emilia School of Medicine
Andrea Cossarizza, M.D., Ph.D., is Full Professor of Pathology and Immunology and Director of the School of Specialization in Clinical Pathology, University of Modena and Reggio Emilia School of Medicine. From June 2016, he is President-Elect of the International Society for Advancement of Cytometry (ISAC). He has over 30 years of experience in immunology, particularly in the development and use of original cytometric approaches for sophisticated and innovative analysis. His longstanding research commitments are centered on identifying the molecular and cellular basis of the involvement of the immune system in several diseases and infections, such as HIV/AIDS, hepatitis, and sepsis. His interests also embrace different physiopathological conditions, including those of neurodegenerative origin (multiple sclerosis, Alzheimer’s disease, amyothrophic lateral sclerosis) or human aging, either physiological (with the model of healthy centenarians) and pathological (Down’s syndrome), along with inflammaging. During the past decade he has built expertise in the clinical application of new methods for the identification of rare cellular subsets to patients affected by HIV infection and to patients undergoing liver transplantation, as well as in patients suffering from multiple sclerosis or septic shock. Such methods now allow a comprehensive characterization of the functional activities of these cells.
Prof. Cossarizza has published more than 300 papers in peer-reviewed international journals, authored over 90 papers and chapters on books or conference proceedings and presented over 450 communications to conferences and meetings. His papers have received more than 19,000 citations.
Dr. Anna Brooks
University of Auckland, New Zealand
Dr. Anna Brooks received her Ph.D. in Immunology in 2008 at the University of Auckland, New Zealand where she has since been working as a Maurice Wilkins Centre Research Fellow. Anna also manages the Flow Cytometry centre within the Science Faculty and is experienced in multicolour panel development to characterise complex cellular populations in digested human tissues. Anna initially specialised in human immunology (T cells, antigen presenting cells, APCs) with a focus on developing multicolour panels to characterise and monitor immune cells in both blood and digested tissues. These panels include a 17 colour T cell panel utilised in a clinical trial, as well as a number of T cell, lymphocyte, and monocyte/ dendritic cell panels (10+ colours). More recently, Anna’s primary research interest lies in using a 17-colour mesenchymal/ vascular panel to dissect the heterogeneity of the primary (pre-culture) phenotype of mesenchymal cells in digested human tissues, such as human skin and adipose tissue. Anna is especially interested in characterising the diversity of the mesenchymal precursor/ progenitor cell populations present in adipose tissue with the hope of defining cells that have true multipotent differentiation potential.
Dr. Anis Larbi
Singapore Immunology Network, A*STAR
Anis Larbi obtained his Ph.D. in immunology from the University of Sherbrooke (Canada) while working at the Research Center on Aging. He then moved to the Center for Medical Research at the University of Tubingen (Germany). He was recruited by A*STAR in 2010 and is now running his own laboratory. His research interests focus on the biology of aging and the use of biotechnologies such as Flow Cytometry to support his research. He runs a research group at the Singapore Immunology Network (Biology of Aging Laboratory) and is Head of the Flow Cytometry Platform (SIgN and A*STAR), one of the largest in SouthEast Asia. Anis Larbi was part of the ISAC Marylou Ingram Scholar Program and is part of the CYTO Asia 2017 Organising Committee.
Dr. Attila Tarnok
Editor-in-Chief of Cytometry Part A
International Society for Advancement of Cytometry (ISAC)
Institute for Medical Informatics, Statistics and Epidemiology (IMISE),
University of Leipzig, Germany
Dr. Attila Tarnok is professor for immunology and cytomics. He studied biology and received his Ph.D. in biophysics at the University Hamburg. His postdoctoral positions were at the Bernhard-Nocht-Institute for Tropical Diseases and the Center for Molecular Neurobiology, Hamburg, and at the MRC Hammersmith, London. From 1996-2017 he directed the research department of Pediatric Cardiology at the Heart Center, University Leipzig. Presently, he is Editor-in-Chief of Cytometry Part A, Fellow of the SPIE and Guest Professor at the Shandong University, Jinan, China. He has authored over 300 publications, edited several textbooks including “Cellular Diagnostics” and organizes conferences on high-content single-cell analysis. His research interests are new technologies for high-content cytometry and translation into predictive medicine.
Dr. Bill Telford
Director of the Flow Cytometry Core Laboratory
NCI Experimental Transplantation and Immunology Branch
Bill Telford received his Ph.D. in microbiology from Michigan State University in 1994, where his laboratory developed some of the earliest techniques for flow cytometric detection of apoptosis. He received his postdoctoral training in immunology at The University of Michigan Medical School and was appointed assistant scientist at the Hospital for Special Surgery in New York City from 1997 to 1999. Dr. Telford became a Staff Scientist at the National Cancer Institute, National Institutes of Health in 1999, and is currently an Associate Scientist and Director of the Flow Cytometry Core Laboratory in the NCI Experimental Transplantation and Immunology Branch. Dr. Telford’s main research interests include: instrument development, particularly in the area of novel solid state laser integration into flow cytometers; flow cytometric stem cell detection and characterization; and functional characterization of early apoptosis by flow and image cytometry.
Dr. Brent Wood
Professor and Director, Hematopathology Laboratory
University of Washington
Brent Wood obtained his M.D. and Ph.D. from Loma Linda University followed by a residency in Anatomic and Clinical Pathology at the University of Washington in Seattle. After a fellowship in Hematopathology at the University of Washington, Dr. Wood accepted a faculty position in the Department of Laboratory Medicine at the University of Washington where he is currently Professor and Director of the Hematopathology Laboratory. His responsibilities include clinical service work, translational research, and teaching Hematopathology to trainees. Flow cytometry is an area of particular interest. He is responsible for implementing the first use of 9 and 10 color flow cytometry in the clinical laboratory and exploiting its potential for the identification of minimal residual disease in acute lymphoid leukemia and acute myeloid leukemia. His laboratory serves as one of two national reference laboratories for the identification of minimal residual disease in childhood acute lymphoblastic leukemia for the Children’s Oncology Group, is involved in similar protocols with the Southwest Oncology Group, and provides contract testing for a number of biotechnology and pharmaceutical companies. Dr. Wood lectures both nationally and internationally on clinical applications of flow cytometry and is Past President of the International Clinical Cytometry Society.
Dr. David Hedley
Princess Margaret Hospital
David Hedley completed his higher specialist training in medical oncology, combined with a graduate program in tumour immunology, at the Royal Marsden Hospital, University of London. He was junior faculty at the University of Sydney, Australia, 1981-1989 where he was responsible for the development of flow cytometry applications to cancer biology, including the technique for DNA content analysis using paraffin-embedded tissue that played a major role in the early development of clinical flow cytometry. Since 1990 he has been Senior Scientist/Senior Staff Physician at the Princess Margaret Hospital, and Professor of Medicine at the University of Toronto, Canada, with a major focus on pancreatic cancer. His laboratory makes extensive use of patient-derived xenografts that recapitulate the clinical spectrum of the disease, and develops flow cytometry techniques to study complex biological processes linked to experimental treatment development. Since 2015 he has been collaborating closely with the team of scientists at Fluidigm Canada who have been developing the commercial imaging mass cytometer.
Dr. Elaine Coustan-Smith
Principal Research Scientist, Department of Paedatrics
National University of Singapore
Dr. Coustan-Smith is a principal research scientist in the Department of Paedatrics at the National University of Singapore. Much of Dr. Coustan-Smith’s career has been devoted to the development of novel approaches to the classification and monitoring of leukemia and lymphoma, with a particular focus on detection of minimal residual disease by flow cytometry. Before moving to Singapore in 2011, she was Laboratory Manager in the Department of Oncology at St. Jude Children’s Research Hospital in Memphis, Tennessee. Prior to that, she was Chief Medical Laboratory Scientific Officer in the Department of Immunology at the Royal Free Hospital, London.
Dr. Elizabeth Forbes-Blom
Malaghan Institute of Medical Research, Wellington, New Zealand
Dr. Elizabeth Forbes-Blom leads a team of immunologists with expertise in inflammatory and infectious diseases at the Malaghan Institute of Medical Research based in Wellington, and is a member of the High-Value Nutrition Science Leadership Team – charged with providing better understanding of how food supports respiratory immune defence against infection and manages pollution-driven inflammation. Dr. Forbes-Blom completed her Ph.D. studies at the John Curtin School of Medical Research, Australian National University and Cincinnati Children’s Hospital Medical Center in the US. Following this, she returned home to New Zealand with the purpose of building a research programme that takes an immunological approach to health and disease to move our understanding beyond local immune responses in the gut to encompass the dynamic interplay between food, the immune cellular networks and the microbiota within.
Dr. Evan Newell
Singapore Immunology Network, A*STAR
Evan Newell completed his B.Sc. in Immunology at McGill University and Ph.D. in Physiology at the University of Toronto. As a post-doc at Stanford University, he worked with Mark Davis on biophysical aspects of T cell antigen recognition and initiated the use of mass cytometry for the study of human T cell responses. Now as a principal investigator at the Singapore Immunology Network (SIgN), his lab continues to apply and develop novel approaches for identifying and thoroughly characterizing antigen-specific T cells. This includes the development of combinatorial peptide-MHC tetramer staining used in conjunction with mass cytometry for in-depth analysis of cellular phenotype and function. A major goal of lab is to identify useful biomarkers of clinical outcomes that take advantage of these modern approaches with particular focus on human chronic infection and cancer.
Dr. Jinmiao Chen
Singapore Immunology Network, A*STAR
Dr. Jinmiao Chen is a computational biologist. She got her Bachelor’s degree in Computer Science, Ph.D. in machine learning and artificial neural networks. After her Ph.D., she joined the Bioinformatics service core of SIgN, A*STAR Singapore in 2009. She has worked closely with bench scientists from SIgN and other research institutes to analyze microarray, next generation sequencing and microbiome data. In 2014 when high-dimensional mass cytometry and single-cell RNA-sequencing become available in Singapore, she developed a series of new computational methodologies for analyzing high-dimensional single-cell data, such as cytofkit, flowAI, Mpath and etc. Since 2014, she started her own research lab – single-cell computational/system immunology (SCCI) lab. Her lab currently focuses on integrated analysis of high-dimensional flow/mass cytometry and single-cell RNA-sequencing data, with the aim of studying cellular diversity, cell lineage, cell-cell interaction, cell movement and rare cell populations. The lab carries out independent research to develop new data analysis methods, and is massively involved in data analysis through collaboration. In addition, the lab also initiates and runs biological research projects together with clinicians and biologists.
Dr. Jordi Petriz
José Carreras Leukaemia Foundation
Jordi Petriz received his B.Sc. degree in Biochemistry and Animal Biology from the University of Barcelona. He then pursued his Ph.D. at Barcelona after acceptance at the Cryobiology and Cell Therapy Department, Cancer Research Institute. In 1998 he obtained his Ph.D. in Physiology and Immunology specializing in functional-based mechanisms on multidrug resistance against anticancer agents. The cytomic functional approach was used to account for multidrug transporters and drug resistance profiling in highly refractory cancer cells. As a postdoctoral fellow he applied new cytomic approaches to address questions on whole blood counting of CD34+ progenitor cells. Since 2000, he joined the Subcommittee on Quality Assessment of Hematopoietic Stem Cell Grafts (established by the European Group for Bone Marrow Transplantation). Since then he has been leading different research projects as Principal Investigator. Jordi Petriz has authored or co-authored nearly 100 research contributions; some in high impact Journals including Nature Medicine and Leukemia. His current work focuses on linking stemness with ABC transporters. He is studying several genes involved in different aspects of stem cell activation, including some that encode for multidrug resistance transporters, and others that regulate self-renewal and differentiation. He was President of the Iberian Society for Cytometry (SIC) from 2007 to 2015. He finally joined the Jose Carreras Leukemia Research Institute in Barcelona (Spain) at the beginning of 2015, when he also joined the European Society for Clinical Cell Analysis (ESCCA) as Councilor on the Executive Board.
Prof. Keisuke Goda
Department Chair, Department of Chemistry
University of Tokyo
Keisuke Goda is Department Chair and a Professor of Physical Chemistry in the Department of Chemistry at the University of Tokyo and holds an adjunct faculty position at UCLA. He obtained his B.A. degree summa cum laude from UC Berkeley in 2001 and his Ph.D. from MIT in 2007, both in physics. At MIT, he worked on the development of quantum-enhancement techniques in LIGO for gravitational-wave detection. In 2012, he joined the University of Tokyo as a professor. His research group focuses on the development of innovative laser-based molecular imaging and spectroscopy methods for data-driven life sciences and medicine. He has been awarded the Gravitational Wave International Committee Thesis Award (2008), Burroughs Welcome Fund Career Award (2011), Konica Minolta Imaging Science Award (2013), IEEE Photonics Society Distinguished Lecturers Award (2014), and WIRED Audi Innovation Award (2016). He serves as an Associate Editor for APL Photonics (AIP Publishing) and a Young Global Leader for the World Economic Forum.
Dr. Matthew Linden
Associate Professor of Haematology
University of Western Australia
Dr. Linden is internationally recognized for his expertise in the characterization of platelet function in health and disease, the detection of antiplatelet drug resistance and his contribution to the development of new antiplatelet therapies. His research has been featured thrice on the cover of journals and, with more than 1,800 citations, has had a significant impact on the fields of haematology and cytometry. He was named a 2016 Marylou Ingram Scholar by the International Society for the Advancement of Cytometry in recognition for his development of novel cytometry techniques for blood platelets and platelet-immune systems biology.
Prof. Narinder Mehra
Head of Transplant Immunology & Immunogenetics
All India Institute of Medical Sciences, New Delhi
Professor Narinder Mehra is the National Professor, Former Dean (Research) and Head of Transplant Immunology & Immunogenetics at the All India Institute of Medical Sciences, New Delhi. He has made significant contributions in defining immune mediators influencing graft success in organ and bone marrow transplantation, genome diversity of HLA and towards developing MHC based vaccination approaches in infectious diseases. He is a Fellow of the Indian Academy of Sciences (FNASc), Fellow of the Indian National Science Academy (FNA), Member Honoris Causa of the Hungarian Academy of Sciences and ‘Fellow’ of The World Academy of Sciences (FTWAS). He is the chief Editor of ‘Frontiers in Immunology’ special topic, ‘Clinical relevance of antibodies in solid organ transplantation. The French President conferred on him the title of ‘Chevalier of the National Order of Merit’. He also received the highest International award from the Iranian Research Organization for Science and Technology.
Prof. Paul Wallace
International Society for the Advancement of Cytometry (ISAC)
Paul Wallace is an internationally recognized expert in clinical flow cytometry with a strong background in immunology and research interests in antigen processing and presentation. He is President of the International Society for the Advancement of Cytometry (ISAC) and a past Councilor of the International Clinical Cytometry Society (ICCS). He is Director of Flow and Image Cytometry and Professor Oncology at Roswell Park Cancer Institute (RPCI) in Buffalo, New York Flow and Image Cytometry at RPCI offers a strong combination of clinical and research missions and under Dr. Wallace’s direction actively works to build translational synergies between them. The clinical laboratory is focused on the diagnosis and monitoring of patients with leukemia and lymphoma. Recent activities have focused on minimal residual disease testing. RPCI’s NCI supported CCSG Flow and Image Cytometry Core Resource services and maintains flow cytometric and imaging equipment for researchers at Roswell Park, throughout the Buffalo metropolitan area. RPCI is also the Core Immunophenotyping facility for multiple Clinical Protocols both locally and nationally.
Prof. Salvatore Albani
SingHealth Translational Immunology and Inflammation Centre
Professor Salvatore Albani, M.D., Ph.D, is currently a Professor with the Duke-NUS Graduate Medical School Singapore, the Director of the SingHealth Translational Immunology and Inflammation Centre, and a Senior Consultant and Senior Clinician Scientist at KK Women’s and Children’s Hospital.
His fundamental research interest is in understanding human immunity and contributing to the knowledge of therapeutic and diagnostic advancements. He developed several innovative approaches in the area of induction and maintenance of immune tolerance in humans, being responsible for the whole translational process from idea to conclusion of Phase II clinical trial in autoimmune inflammatory diseases. The technology platform has applications in diseases that could benefit from a restoration of immune tolerance. This translational research itinerary has been the original backbone of his career, as witnessed by numerous publications and by approximately 100 patents. Combined, these approaches span both ways across the gradient of Translational Medicine.
Prof. Albani co-founded and is a charter member of the Childhood Arthritis and Rheumatology Research Alliance (CARRA). He also co-founded and serves as President of the nonprofit foundation Eureka Institute for Translational Medicine. Prof. Albani received several awards, including a Nature Biotechnology award for career achievement and the Singapore Translational Research (STaR) Investigator Award from the NMRC Singapore.
Mr. Simon Monard
Head of Flow Cytometry
The Walter Eliza Hall Institute
Simon graduated with a BSc Hons from University College London in Zoology and completed a Masters in Immunology at Kings College London shortly thereafter. He started working in a flow cytometry lab within Imperial Cancer Research Fund (now Cancer Research UK). For the last 30 years Simon has been managing cytometry labs in the UK, Portugal, the United States and now Australia. He is currently Head of Flow Cytometry at the Walter and Eliza Hall Institute.
His interests include optimizing and improving instrument performance, high dimensional cytometry and single cell biology.
Dr. Sindhu Cherian
Associate Professor of Laboratory Medicine
University of Washington, Seattle
Sindhu Cherian, M.D., is Associate Professor of Laboratory Medicine at the University of Washington in Seattle. She is board certified in clinical pathology and hematopathology. Her clinical activities include flow cytometry, morphology, and laboratory hematology and she serves as co-director of the flow cytometry laboratory. Her research interests are primarily in clinical flow cytometry, with a focus in test development. In addition, she has a strong interest in education and serves on the education committee of the International Clinical Cytometry Society (ICCS). She is course director of the ICCS clinical flow cytometry course and is on the course committee of the Clinical Cytometry Education Network. Dr. Cherian received her medical degree from Emory University in Atlanta, followed by a residency and fellowship at the University of Pennsylvania.
Dr. Susanna Mandruzzato
Assistant Professor of Immunology, Department of Surgery Oncology and Gastroenterology
University of Padova, Italy
Susanna Mandruzzato received her Ph.D. in Oncology at the University of Padova and completed her postdoctoral training at the Ludwig Institute for Cancer Research in Brussels. Since then, her research activities have focused on different aspects of tumor immunology.
She is currently Assistant Professor of Immunology at the Department of Surgery Oncology and Gastroenterology of the University of Padova and Research Scientist at the IOV-IRCCS, Padova, where she supervises a laboratory of translational research on immune evasion mechanisms in cancer patients. In particular, she contributed to the characterization of human myeloid-derived suppressor cells (MDSC) in patients with solid tumors. She is coordinator of the proficiency panel to harmonize MDSC phenotyping under the guidance of CIMT Immunoguiding Group (CIP).
Ms. Teri Oldaker
Director of Flow Cytometry
Genoptix Medical Laboratory, California
Teri is a licensed Clinical Laboratory Scientist with over 40 years clinical laboratory and 34 years flow Cytometry experience in reference laboratory settings. She is currently the Director of Flow Cytometry at Genoptix Medical Laboratory in Carlsbad, California. Teri serves on the board of the International Clinical Cytometry Society (ICCS) as Secretary /Treasurer and is on the faculty of both the ICCS and Clinical Cytometry Education Network (CCEN) Flow Courses. She is a member of the following ICCS committees: Advocacy, Certification, Nominating and Quality and Standards Committees. She has authored 4 book chapters and over 40 publications in the field of Flow Cytometry.
Dr. Thomas Ashhurst
High-dimensional Cytometry Specialist
Sydney Cytometry Core Facility and Discipline of Pathology, The University of Sydney
Thomas Ashhurst is a high-dimensional cytometry specialist at the Sydney Cytometry core facility and Discipline of Pathology at the University of Sydney. Tom performed his Ph.D. research in the laboratory of Prof. Nicholas King at the University of Sydney, using advanced cytometry techniques to investigate how bone marrow stem and progenitor cells are mobilised in response to viral infection of the CNS. To do this, he played a key role in developing a new 10-laser 30-parameter BD ‘LSR-X’ special order research product (SORP) platform to analyse flow cytometry panels of up to 30-parameters, as well as developing Australia’s first mass cytometry (CyTOF) panels of over 30 parameters. Tom’s current research efforts focus on combining the power of high-dimensional cytometry techniques with in-depth biological insight, to reveal the mechanisms of immunity and disease. These efforts are supplemented by developing analysis approaches to high dimensional data, utilising and improving tools as us viSNE/tSNE. Tom is also a consulting member of the Ramaciotti Facility for Human Systems Biology (RFHSB) at the University of Sydney and Centenary Institute, a past council member (student liaison officer) and current member of the Australian Cytometry Society (ACS), as well as a member of both the Australasian Society for Immunology (ASI), and International Society for the Advancement of Cytometry (ISAC).
Dr. Xunbin Wei
Head, Optical Molecular Imaging Laboratory
Shanghai Jiao Tong University
Xunbin Wei obtained his Ph.D. in Biophysics from the University of California at Irvine in 1999. He had been a Postdoctoral researcher at Harvard Medical School, and a faculty member at Wellman Center for Photomedicine, Harvard Medical School, before returning to China in 2006. Dr. Wei was a professor in the Department of Chemistry in Fudan University from 2006 to 2010. He joined Shanghai Jiao Tong University (SJTU) in 2011 and currently is the head of the Optical Molecular Imaging Laboratory and distinguished professor in School of Biomedical Engineering. Prof. Wei has authored and co-authored more than 60 papers in peer reviewed scientific journals, including Nature, PNAS, and recently Nature Communications.
Dr. Wei is currently vice chairman of the Chinese Association of Laser Medicine. He is the recipient of the “National Distinguished Young Scientist Award”. He has developed the “In Vivo Flow Cytometry”. He has won one US patent and three Chinese invention patents. One medical device invented by him has won Chinese sFDA approval. Currently Dr. Wei is the Associate Editor for Cytometry Part A and is currently an SPIE Fellow.